Oxford University About the DTU › Home page
› Staff
› Conferences
› Publications
  · 4-T
  · ADOPT
  · AFORRD
  · DREAM
  · EDIT
  · FHS
  · HOMA Calculator
  · ISAT
  · LDS
  · NAVIGATOR
  · Outcomes Model
  · Risk Engine
  · TRG
  · UKPDS

› Slides
› Webcasts
› Contact
› Find us

Software › HOMA Calculator
› Outcomes Model
› Risk Engine

Current Studies › 4-T
› ACE
› EXSCEL
› TECOS
› Translational

Completed Studies › ADOPT
› AFORRD
› DREAM
› EDIT
› FHS
› ISAT
› LDS
› UKPDS
› UKPDS~PTM

Intranet Search
Oxford Clinical Trials Logo
CTU Logo
Atorvastatin in Factorial with Omega-3 Fatty Acids Risk Reduction in Diabetes AFORRD Logo

Publications (n=2)

2010AFORRD
Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: A randomised placebo controlled trial
H.A.W. Neil, U. Ceglarek, J. Thiery, S. Paul, A. Farmer, R. R Holman
Atherosclerosis 2010;213:512-517
2009AFORRD
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA on behalf of the AFORRD study group
Diabetologia 2009;52:50 - 59
[Full text] [Abstract]
 

Diabetes Trials Unit

AFORRD Office, Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ, UK
Tel: +44 (0)1865 857246     Fax: +44 (0)1865 857256   Email: dtu@dtu.ox.ac.uk

Home | Freedom of Information | Privacy Policy | Copyright | Accessibility | OCDEM | NDM | Oxford University